Jupiter Topco LLC Purchases New Position in Teleflex Incorporated $TFX

Key Points

• Jupiter Topco LLC acquired 4.34 million Teleflex shares worth approximately $550.5 million, giving it a 10.25% stake. Institutional investors and hedge funds collectively own 95.62% of the company.
• Analysts have a consensus “Hold” rating on Teleflex, with an average price target of $152.90; Piper Sandler raised its target to $169 while maintaining an overweight rating.
• Teleflex exceeded quarterly earnings and revenue expectations, reporting $1.76 EPS and $570.33 million in revenue, while revenue rose 28.9% year over year. The company also declared a quarterly dividend of $0.34 per share, representing a 1.0% yield.

Jupiter Topco LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,342,512 shares of the medical technology company's stock, valued at approximately $550,456,000. Jupiter Topco LLC owned about 10.25% of Teleflex at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of TFX. BlackRock Inc. acquired a new stake in Teleflex during the 2nd quarter worth $688,537,000. AQR Capital Management LLC lifted its holdings in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock worth $287,603,000 after acquiring an additional 1,956,811 shares in the last quarter. Irenic Capital Management LP acquired a new position in Teleflex in the first quarter valued at about $104,061,000. Pzena Investment Management LLC acquired a new position in Teleflex in the second quarter valued at about $76,462,000. Finally, Norges Bank bought a new stake in shares of Teleflex in the fourth quarter worth about $66,076,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. Piper Sandler reaffirmed an "overweight" rating and set a $169.00 price target (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. Zacks Research raised Teleflex from a "strong sell" rating to a "hold" rating in a research note on Tuesday, April 28th. UBS Group raised their target price on shares of Teleflex from $145.00 to $158.00 and gave the stock a "neutral" rating in a report on Tuesday, August 11th. Truist Financial lifted their price target on shares of Teleflex from $143.00 to $150.00 and gave the company a "hold" rating in a research note on Monday, August 10th. Finally, Wells Fargo & Company upped their price target on shares of Teleflex from $130.00 to $138.00 and gave the company an "equal weight" rating in a report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Teleflex presently has a consensus rating of "Hold" and a consensus target price of $152.90.

Teleflex Stock Performance

Shares of Teleflex stock opened at $140.07 on Wednesday. The firm has a market cap of $5.93 billion, a price-to-earnings ratio of -6.01, a price-to-earnings-growth ratio of 0.92 and a beta of 0.81. The stock's 50-day moving average is $133.11 and its 200-day moving average is $125.37. Teleflex Incorporated has a one year low of $100.18 and a one year high of $145.00. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.48. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The company had revenue of $570.33 million during the quarter, compared to analysts' expectations of $559.59 million. During the same period in the prior year, the firm earned $3.73 earnings per share. Teleflex's revenue for the quarter was up 28.9% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Equities analysts predict that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex's dividend payout ratio (DPR) is currently -5.84%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source